Edwards Lifesciences Corp (EW)

Financial leverage ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total assets	US$ in thousands	13,055,300	9,363,200	8,292,500	8,502,600	7,237,100
Total stockholders’ equity	US$ in thousands	9,998,400	6,650,000	5,806,700	5,835,900	4,574,300
Financial leverage ratio		1.31	1.41	1.43	1.46	1.58

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $13,055,300K ÷ $9,998,400K
= 1.31

The financial leverage ratio of Edwards Lifesciences Corp has displayed a downward trend from 1.58 in 2020 to 1.31 in 2024. This indicates that the company's reliance on debt to finance its operations has decreased over the years. A lower financial leverage ratio suggests a healthier financial position as it signifies a reduced level of financial risk and lower dependency on debt financing. Edwards Lifesciences Corp seems to have effectively managed its debt levels, potentially leading to improved financial stability and sustainability in the long term.